Seattle Multidisciplinary Lung Cancer Conference

Seattle, WA US
October 23, 2021

This accredited continuing education activity “Seattle Multidisciplinary Lung Cancer Conference”, will feature leading experts in lung cancer who will provide a comprehensive overview recent advances and controversies in management of lung cancer. The goal of this activity is to improve the knowledge, competence and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for their patients with lung cancer. Expert faculty will place key abstract findings from 2021 ASCO Annual Meeting (ASCO2021) and the IASLC 2021 World Conference on Lung Cancer (WCLC2021) into clinical context and discuss how the results may change the current standard of care. 

Conference highlights:

  • Innovative and integrated learning environment.
  • Audience response system
  • Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
  • Opportunities to network with colleagues and interact with faculties; enduring materials allow learners opportunities to learn at their convenience.
  • Program topics can immediately be applied to clinical practice.

Target Audience

This activity is directed towards clinical care team who treat patients with lung cancer:

  • Oncologists
  • Oncology fellows
  • Oncology nurses
  • Oncology nurse practitioners
  • physician assistants,
  • Oncology pharmacists

Learning Objectives

At the conclusion of the activity, participants will be able to:

  • Review potentially practice changing abstracts presented at 2021 ASCO Annual Meeting (ASCO2021) and the IASLC 2021 World Conference on Lung Cancer (WCLC2021)
  • Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in standards of care in lung cancer
  • Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact management of patients with lung cancer
  • Integrate emerging evidence into treatment paradigms for treatment of lung cancer.

COVID-19 Precautions

COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in. 

Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.

Course summary
Available credit: 
  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
  • 0.00 Participation
Course opens: 
07/01/2021
Course expires: 
10/01/2022
Event starts: 
10/23/2021 - 7:00am
Event ends: 
10/23/2021 - 5:00pm
Cost:
$100.00

Conference Chair: Dr. Joseph Rosales

All times are listed in pacific time zone.

06:30 AM to 07:45 AM PST - Registration/Networking

07:45 AM to 08:00 AM PST - Opening Remarks 


08:00 AM to 09:45 AM PST:  Diagnosis/Next generation sequencing

Moderator: Dr. Andrea Veatch

08:00 AM – 08:20 AM PST: Precision oncology – best practices in tissue/blood testing Dr. Tejas Patil

08:20 AM – 08:40 AM PST: Detection & Clinical Application of Minimal Residual Disease in Lung Cancer Dr.  Jack West

08:40 AM – 09:00 AM PST: Pathologic assessment of NSCLC after neoadjuvant therapy Dr. Haodong Xu

09:00 AM – 09:45 AM PST: Case-based Discussion Dr. Andrea Veatch

 


09:45 AM to 10:15 AM PST: BREAK & EXHIBITS/PRODUCT THEATER


*9:45 AM to 10:15 AM - Breakfast & Learn in Parkside Room 

Retevmo® (selpercatinib): A precision-based therapy for certain RET-driven cancers.

VISIT RETEVMO.COM/TEST TO LEARN MORE ABOUT TESTING METHODS FOR THIS ACTIONABLE BIOMARKER

*This activity is sponsored by Lilly Oncology and is not part of the CME program

 


10:15 AM to 12:00 PM PST: Resectable non-small cell lung cancer 

Moderator: Dr. Joseph Rosales

10:15 AM – 10:35 AM PST: Sublobar resection in NSCLC Dr. Madhan Kuppusamy

10:35 AM – 10:55 AM PST: Beyond chemotherapy – adjuvant targeted therapy in NSCLC Dr. Sandip Patel

10:55 AM – 11:15 PM PST: Checkpoint inhibitors in neoadjuvant/adjuvant role in   NSCLC Dr. Christina Baik

11:15 AM – 12:00 PM PST: Case-based discussion Dr. Joseph Rosales/Dr. Jed Gorden

 


12:00 PM – 13:00 PM PST: POSTER SESSION/LUNCH/EXHIBITS/PRODUCT THEATER

 


*12:00 to 12:30 PM in Parkside Room (2nd Floor) - Lunch and Learn with Dr. Hatin Husain, Medical Oncologist at the University of California San Diego.

EGFR EXON 20 INSERTION MUTATIONS - EMERGING IMPLICATIONS FOR THE MANAGEMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)

Visit https://www.rybrevanthcp.com to learn more about this product.

*This activity is sponsored by Janssen Biotech and is not part of the CME activity


13:00 PM – 15:00 PM PST: Unresectable/metastatic non-small cell lung carcinoma 

Moderator: Dr. John Paul Flores

13:00 PM – 13:20 PM PST: Molecular directed therapy of advanced NSCLC in 2021 Dr. Kathryn Gold

13:20 PM – 13:40 PM PST: Antibody-drug conjugates in NSCLC Dr. Rafael Santana-Davila

13:40 PM – 14:00 PM PST: Emerging biomarker targets for checkpoint inhibitor therapy Dr. Wade T. Iams

14:00 PM – 14:45 PM PST: Case-based Discussion Dr. Jaideep Shenoi/Dr. John Paul Flores  


14:45 PM – 15:15 PM PST: BREAK & EXHIBITS


15:15 PM – 17:00 PM PST: Small cell lung carcinoma/mesothelioma

Moderator: Dr. Joseph Rosales

15:15 PM – 15:35 PM PST: Surgery vs radiation in early-stage small cell lung cancer Dr. Adam Bograd

15:35 PM – 15:55 PM PST: Immunotherapy and targeted therapy in small cell lung cancer Dr. Renato G. Martins

15:55 PM – 16:15 PM PST: Pulmonary neuroendocrine tumors - recent updates Dr. Aman Chauhan

16:15 PM – 17:00 PM PST: Case-based discussion Dr. Joseph Rosales

 

Crowne Plaza Seattle - Downtown
1113 6th Ave
Seattle, WA 98101
United States

A limited number of rooms have been reserved at a discounted rate of $159/night for use by the participants of this conference.

You must mention Binaytara Foundation/Lung Cancer Symposium while booking to receive the discounted group rate. Follow the link below or call 1-888-233-9527 to book your room. 

Hotel Booking Link

All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. If a guest does not cancel a reservation by 6pm the day of arrival, then Hotel may charge the credit card one night’s room fee plus any applicable taxes.

TEJAS PATIL, MD

Assistant Professor

Medicine University of Colorado Hospital

MADHAN KUPPUSAMY, MD, FRCS  

Thoracic Surgery

Virginia Mason Medical Center

ANDREA VEATCH, MD

Hematologist/Oncologist

Northwest Medical Specialties Puyallup

WADE T. IAMS, MD

Assistant Professor of Medicine

Vanderbilt University Medical Center

JOSEPH ROSALES, MD 

Oncologist 

Virginia Mason Medical Center

ADAM JASON BOGRAD, MD

Thoracic Surgeon

Swedish Issaquah Hospital

CHRISTOPHER R. GILBERT, MD

Pulmonologist

Swedish Medical Center

JED GORDEN, MD

Pulmonologist

Swedish Medical Center

JACK WEST, MD

Medical Oncologist

City of Hope Comprehensive Cancer Center

YOSHIO INOUE, MD

Medical Oncology 

The Everett Clinic - Providence Regional Cancer Partnership

AMAN CHAUHAN, MD

Assistant Professor of Medicine

UK Markey Cancer Center

HAODONG XU, MD, PhD

Professor

University of Washington School of Medicine

SANDIP PATEL, MD

Medical Oncologist

Associate Professor of Medicine  

Moores Cancer Center at UC San Diego Health

KATE GOLD, MD

Medical Oncologist

Associate Professor of Medicine   

Moores Cancer Center at UC San Diego Health

 

 

CHRISTINA BAIK, MD, MPH

Physician

Seattle Cancer Care Alliance

Associate Professor, Medicine

University of Washington School of Medicine

Associate Professor, Clinical Research Division

Fred Hutchinson Cancer Research Center

RAFAEL SANTANA-DAVILA, MD

Medical Director, Infusion and Pharmacy Services

Seattle Cancer Care Alliance

Associate Professor, Medicine and Oncology

University of Washington School of Medicine

Physician

UW Medicine

Associate Professor, Clinical Research Division

Fred Hutchinson Cancer Research Center 
  

 

CME/CE Information:

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours:

Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.


ABSM Maintenance of Certificate Recognition Statement:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Acknowledgment of commercial support

This activity has been supported with independent medical education grant(s) from the following companies:

  • Pfizer, Inc.
  • AstraZeneca
  • Regeneron
  • Exact Sciences
  • Jazz Pharmaceuticals

Available Credit

  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
  • 0.00 Participation

Please visit our exhibitors and product theater sponsors in the exhibit hall - Yellowstone Room.

The Product Theaters are in Parkside Room (2nd Floor by the elevator).

Breakfast and Lunch will be available in the Parkside Room and Exhibit Hall during the designated hours. 

Price

Cost:
$100.00
Please login or register to take this course.

COVID-19 Precautions

COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in. 

Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.


Registration Fees

Physicians (MD/DO) - $125

Non-Physician (RN/NP/PA/PharmD) - $75 

Residents/Fellows - $50


Industry representative - $550

Displaying company representative (not covered by the display fee) - $450.

If you want to register to attend only, and do not need CME/CE credits, please sign up using this form Attend only registration 

If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients.

CANCELLATION POLICY

You may cancel your enrollment at any time. cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is cancelled by August 15, 2021.
  • No refunds will be issued if registration is cancelled after that date.  

No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.